Chloraprep one-step and Sarafem drug interactions - a phase IV clinical study of FDA data
Summary:
We study 954 people who take Chloraprep one-step (chlorhexidine gluconate; isopropyl alcohol) and Sarafem (fluoxetine hydrochloride). There is no drug interaction reported.
The study analyzes what interactions people have when they take Chloraprep one-step and Sarafem. It is created by eHealthMe based on reports the from the FDA, and is updated regularly.
What is Chloraprep one-step?
Chloraprep one-step has active ingredients of chlorhexidine gluconate; isopropyl alcohol. eHealthMe is studying from 582 Chloraprep one-step users. Check the latest studies of Chloraprep one-step.
What is Sarafem?
Sarafem has active ingredients of fluoxetine hydrochloride. It is often used in premenstrual dysphoric disorder. eHealthMe is studying from 372 Sarafem users. Check the latest studies of Sarafem.
No report is found.
Do you take Chloraprep one-step and Sarafem?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Chloraprep one-step (582 reports)
- Sarafem (372 reports)
How the study uses the data?
The study uses data from the FDA. It is based on chlorhexidine gluconate; isopropyl alcohol and fluoxetine hydrochloride (the active ingredients of Chloraprep one-step and Sarafem, respectively), and Chloraprep one-step and Sarafem (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Bactroban cause Hepatic Encephalopathy? - a second ago
- Could Eplerenone cause Thrombocytopenia? - 3 seconds ago
- Drug interactions of Pramine and Xalatan - 8 seconds ago
- Drug interactions of Prednisone and Trimox - 17 seconds ago
- Drug interactions of Alendronic Acid and Ferrous Fumarate - 17 seconds ago
- Drug interactions of Clindamycin Phosphate and Bumetanide - 24 seconds ago
- Could Coumadin cause Heart Valve Surgery? - 28 seconds ago
- Drug interactions of Ademetionine and Methotrexate - 32 seconds ago
- Could Remeron cause Metabolic Encephalopathy? - 37 seconds ago
- Drug interactions of Lidocaine Hydrochloride and Topamax - 40 seconds ago